Genes with linkage or association with type 2 diabetes mellitus

Journal of Pediatric Endocrinology and Metabolism

Volumn 15, Issue SUPPL. 1, 2002, Pages 471-484

  Bastian, William ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Allele sharing; Complex diseases; Genetic dissection; Genomic sequence; Linkage; Linkage disequilibrium; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; INSULIN; PROTEINASE; INSULIN RECEPTOR;

ALLELE; COMORBIDITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GLUCOSE METABOLISM; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHENOTYPE; POPULATION RESEARCH; REVIEW; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; CHROMOSOME MAP; GENETICS; METABOLISM; SECRETION;

CHROMOSOME MAPPING; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; GLUCOSE; HUMAN; INSULIN; INSULIN RESISTANCE; LINKAGE (GENETICS); RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; DIABETES MELLITUS, TYPE 2; HUMANS;

EID: 0036304744     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (127)

1. Candidate genes for type 2 diabetes
2. Use of genome scans to identify susceptibility genes for type 2 diabetes
3. Genetic dissection of complex traits: An overview
4. The essence of SNPs
5. Single nucleotide polymorphisms and the future of genetic epidemiology
6. Genetic mapping
7. Genetic dissection of complex traits
8. Lessons learned from molecular biology of insulin-gene mutations
9. Analysis of parent-offspring trios provides evidence for linkage and association between the insulin gene and type 2 diabetes mediated exclusively through paternally transmitted class III variable number tandem repeat alleles
10. Molecular mechanisms of insulin resistance: Lessons from patients with mutations in the insulin-receptor gene
11. Insulin receptor variant forms and type 2 diabetes mellitus
12. Prevalence of variants in candidate genes for type 2 diabetes mellitus in the Netherlands: The Rotterdam Study and the Hoorn Study
13. Frequency of mutations of insulin receptor gene in Japanese patients with NIDDM
14. NIDDM associated with mutations in tyrosine kinase domain of insulin receptor gene
15. Insulin receptor substrate polymorphisms and type 2 diabetes mellitus
16. The Gly to Arg972 aminoacid polymorphism in IRS-1 affects glucose metabolism in skeletal muscle cells
17. The naturally occurring Gly to Arg 972 aminoacid polymorphism of IRS-1 causes pancreatic B-cell apoptosis
18. Coupling of SUR1 and KIR6.2 specify the properties of the beta cell KATP channels
19. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy
20. Mutations in the Sulfonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews
21. Endosulfine, an endogenous peptidic ligand for the sulfonylurea receptor: Purification and partial characterization from ovine brain
22. Endosulfine, Endogenous ligand for the sulphonylurea receptor: Isolation from porcine brain and partial structural determination of the A form
23. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin
24. Variants in the sulphonylurea receptor gene: Association of the exon 16-3t variant with type II diabetes mellitus in Dutch Caucasians
25. Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians
26. Genetic studies of the sulfonylurea receptor gene locus in NIDDM and in morbid obesity among French Caucasians
27. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene
28. + channel gene (KIR6.2/BIR): A meta-analysis suggests a role in the polygenic basis of type 2 diabetes mellitus in Caucasians
29. Sequence variations in the human KIR6.2 gene, a subunit of the beta cell ATP-sensitive K-channel: No association with NIDDM in white Caucasian subjects or evidence of abnormal function when expressed in vitro
30. Variability of the pancreatic islet beta cell/liver (GLUT 2) glucose transporter gene in NIDDM patients
31. A mutation in the Glut2 glucose transporter gene of a diabetic patient abolishes transport activity
32. A missense mutation in the CD38 gene, a novel factor for insulin secretion: Association with type 2 diabetes mellitus in Japanese subjects and evidence of abnormal function when expressed in vitro
33. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus
34. Familial hyperglycemia due to mutations in glucokinase
35. Glucokinase gene variants in the common form of NIDDM
36. Promoter variation in the liver glucokinase is a risk factor for non-insulin-dependent diabetes mellitus
37. Nucleotide(-258) G-to-A transition variant of the liver glucokinase gene is associated with essential hypertension
38. Mutations in the hepatocyte nuclear factor-4α gene I maturity-onset diabetes of the young (MODY1)
39. A missense mutation in hepatocyte nuclear factor-4α, resulting in a reduced transactivation activity, in human late-onset non-insulin-dependent diabetes mellitus
40. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3)
41. Mutations in the hepatocyte nuclear factor-1α/MODY3 gene in Japanese subjects with early- and late-onset NIDDM
42. Early-onset type 2 diabetes mellitus (MODY4) linked to IPF1
43. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus
44. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes
45. The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes
46. Mutations in NEROD1 are associated with the development of type 2 diabetes mellitus
47. Genetics of mitochondria-related forms of syndromic diabetes mellitus
48. Maternally inherited diabetes and deafness is a distinct subtype of diabetes and associates with a single point mutation in the mitochondrial tRNA(Leu)(UUR) gene
49. Maternally inherited diabetes and deafness (MIDD): A distinct subtype of diabetes associated with a mitochondrial tRNA(Leu)(UUR) gene point mutation
50. Diabetes mellitus is one of the heterogeneous phenotypic features of a mitochondrial DNA point mutation within the tRNALeu(UUR) gene
51. Two novel pathogenic mitochondrial DNA mutations affecting organelle number and protein synthesis. Is the tRNA(Leu)(UUR) gene an etiologic hot spot?
52. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies
53. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation
54. Adult onset limb-girdle type mitochondrial myopathy with a mitochondrial DNA np8291 A-to-G substitution
55. Novel mitochondrial DNA mutation in tRNA(Lys) (8296A→G) associated with diabetes
56. Segregation patterns of a novel mutation in the mitochondrial tRNA glutamic acid gene associated with myopathy and diabetes mellitus
57. Mitochondrial diabetes: Investigation and identification of a novel mutation
58. Deletions of muscle mitochondrial DNA
59. Kearns-Sayre syndrome with muscle mitochondrial DNA deletion
60. An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/Frataxin (Friedreich's ataxia) gene
61. Altered β-cell characteristics in impaired glucose tolerant carriers of a GAA trinucleotide repeat polymorphism in the Frataxin gene
62. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homologue of Frataxin
63. Rad: A member of the Ras family overexpressed in muscle of type ii diabetic humans
64. Overexpression of Rad inhibits glucose uptake in cultured muscle and fat cells
65. Trinucleotide repeats at the Rad locus
66. Analysis of trinucleotide-repeat combination polymorphism at the Rad gene in patients with type 2 diabetes mellitus
67. Polymorphism at the Rad gene is not associated with NIDDM in Finns
68. Stimulation of adipogenesis in fibroblasts by PPARG2, a lipid-activated transcription factor
69. An antidiabetic thiazolidinedione is a higher affinity ligand for peroxisome proliferator-activated receptor G
70. PPARG, the ultimate thrifty gene
71. Dominant negative mutations in human PPARG associated with severe insulin resistance, diabetes mellitus and hypertension
72. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: Identification of a Pro12A1a PPAR gamma 2 missense mutation
73. Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor gamma 2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men
74. A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
75. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
76. Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus
77. Identification of a simple tandem repeat DNA polymorphism in the human glycogen synthase gene and linkage to five markers on chromosome 19q
78. Simple tandem repeat DNA polymorphism in the human glycogen synthase gene is associated with NIDDM in Japanese subjects
79. Association of the glycogen synthase locus on 19q13 with NIDDM in Pima Indians
80. Association between polymorphism of the glycogen synthase gene and non-insulin dependent diabetes mellitus
81. A paired-sibling analysis of the Xbal polymorphism in the muscle glycogen synthase gene
82. Expression of naturally occurring variants in the muscle glycogen synthase gene
83. A missense mutation of the muscle glycogen synthase gene (M416V) is associated with insulin resistance in the Japanese population
84. A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes
85. The 3′-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population
86. Variation in the AU(AT)-rich element within the 3′-untranslated region of PPP1R3 is associated with variation in plasma glucose in Aboriginal Canadians
87. Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with non-insulin-dependent diabetes mellitus
88. The human glucagon receptor encoding gene: Structure, cDNA sequence and chromosomal localization
89. A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus
90. Mutation of the glucagon receptor gene and diabetes mellitus in the UK: Association or founder effect?
91. Association of a glucagon receptor mutation in German patients with familial NIDDM
92. The Gly40Ser mutation in the human glucagon receptor gene associated with NIDDM results in a receptor with reduced sensitivity to glucagon
93. 3-adrenergic receptor gene associated with obesity and type 2 diabetes
94. 2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus
95. 3-adrenergic receptor mRNA in man
96. 3-adrenoreceptors in obesity
97. 3-Adrenergic-receptor gene with features of the insulin resistance syndrome in Finns
98. 3-adrenergic-receptor gene
99. 3-adrenergic-receptor and an increased capacity to gain weight in patients with morbid obesity
100. 3-adrenergic-receptor with NIDDM and body weight gain
101. Expression of rat intestinal fatty acid-binding protein in Escherichia coli
102. Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians
103. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance
104. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance
105. Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance
106. Hormonal regulation of hormone-sensitive lipase in intact adipocytes: Identification of phosphorylated sites and effects on the phosphorylation by lipolytic hormones and insulin
107. Human hormone-sensitive lipase: Genetic mapping, identification of a new dinucleotide repeat, and association with obesity and NIDDM
108. The putative role of the hormone-sensitive lipase gene in the pathogenesis of type 2 diabetes mellitus and abdominal obesity
109. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
110. Combination of polymorphisms in OB-R and the OB gene associated with insulin resistance in Nauruan males
111. Serotonergic control of the organization of feeding and satiety
112. 2c receptor gene and their association with obesity and type II diabetes
113. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications
114. Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan
115. Association of an (A-C)n dinucleotide repeat polymorphic marker at the 5′-region of the aldose reductase gene with retinopathy but not with nephropathy or neuropathy in Japanese patients with type 2 diabetes mellitus
116. An (A-C)n dinucleotide repeat polymorphic marker at the 5′ end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients
117. Association of a human G-protein B3 subunit variant with hypertension
118. G protein B3 subunit 825T allele and its potential association with obesity in hypertensive subjects
119. Interaction of the G Protein β3 subunit T825 allele and the IRS-1 Arg972 variant in type 2 diabetes
120. A genome-wide search for human non-insulin dependent (type 2) diabetes genes reveal a major susceptibility locus on chromosome 2
121. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
122. Guilt by association
123. Calpain: New perspectives in molecular diversity and physiological-pathological involvement
124. Calpain: A protease in search of a function
125. The new enzymology of precursor processing endopeptidases
126. What B-cell defect could lead to hyperproinsulinemia in NIDDM?
127. Obesity and impaired prohormone processing associated with mutation in the human prohormone convertase 1 gene